Literature DB >> 10801290

Relationship between increasing duodenal lipid doses, gastric perception, and plasma hormone levels in humans.

C Feinle1, D Grundy, B Otto, M Fried.   

Abstract

Duodenal lipid causes gastric relaxation, CCK secretion, and nausea. Vasopressin has been implicated in motion sickness-related nausea. We hypothesized that increasing doses of lipid enhance gastric relaxation and CCK-vasopressin secretion, resulting in a dose-related exacerbation of nausea. Nine healthy subjects received isotonic saline or lipid (1, 2, or 3 kcal/min, L1, L2, L3) duodenally. Changes in gastric volume, sensations, and plasma hormone levels were assessed during infusions and isobaric gastric distensions. Lipid infusions increased gastric volume, plasma CCK (but not vasopressin) levels, and gastric compliance during distensions, compared with saline. Plasma CCK levels were related to the dose of lipid administered [CCK levels at 30 min (pmol/l), saline: 1.1 +/- 0.2, L1: 1.8 +/- 0.2, L2: 3.0 +/- 0.2, L3: 4.3 +/- 0.6]. During distensions, nausea increased in intensity with increasing doses of lipid [score (where 0 is no sensation and 100 is strongest sensation), saline: 7 +/- 4, L1: 19 +/- 7, L2: 44 +/- 7, L3: 66 +/- 8]; however, no further rise in plasma CCK occurred. Because neither lipid nor distension alone induced significant nausea, we conclude that the interaction between these stimuli together with a modulation by CCK is responsible for the effects observed. Vasopressin is not involved in lipid- and distension-induced nausea.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10801290     DOI: 10.1152/ajpregu.2000.278.5.R1217

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  10 in total

Review 1.  Measurement of gastrointestinal transit.

Authors:  Henry C Lin; Charlene Prather; Robert S Fisher; James H Meyer; Robert W Summers; Mark Pimentel; Richard W McCallum; Louis M A Akkermans; Vera Loening-Baucke
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

2.  Functional dyspepsia, delayed gastric emptying, and impaired quality of life.

Authors:  N J Talley; G R Locke; B D Lahr; A R Zinsmeister; G Tougas; G Ligozio; M A Rojavin; J Tack
Journal:  Gut       Date:  2005-12-01       Impact factor: 23.059

Review 3.  Frontiers in functional dyspepsia.

Authors:  Noel R Fajardo; Filippo Cremonini; Nicholas J Talley
Journal:  Curr Gastroenterol Rep       Date:  2005-08

4.  Treatment of functional dyspepsia.

Authors:  Smita L S Halder; Nicholas J Talley
Journal:  Curr Treat Options Gastroenterol       Date:  2005-08

Review 5.  Dietary and lifestyle factors in functional dyspepsia.

Authors:  Christine Feinle-Bisset; Fernando Azpiroz
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-08       Impact factor: 46.802

6.  Proximal gastric response to small intestinal nutrients is abnormal in mechanically ventilated critically ill patients.

Authors:  Nam-Q Nguyen; Robert-J Fraser; Marianne Chapman; Laura-K Bryant; Richard-H Holloway; Rosalie Vozzo; Christine Feinle-Bisset
Journal:  World J Gastroenterol       Date:  2006-07-21       Impact factor: 5.742

7.  Role of cognitive factors in symptom induction following high and low fat meals in patients with functional dyspepsia.

Authors:  C Feinle-Bisset; B Meier; M Fried; C Beglinger
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

8.  Appearance of double peaks in plasma concentration-time profile after oral administration depends on gastric emptying profile and weight function.

Authors:  Yukiko Metsugi; Yoshihiro Miyaji; Ken-ichi Ogawara; Kazutaka Higaki; Toshikiro Kimura
Journal:  Pharm Res       Date:  2007-10-23       Impact factor: 4.200

9.  The role of fat and cholecystokinin in functional dyspepsia.

Authors:  M Fried; C Feinle
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

10.  Current treatments in functional dyspepsia.

Authors:  Meredythe A McNally; Nicholas J Talley
Journal:  Curr Treat Options Gastroenterol       Date:  2007-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.